Search - tctmd.com

Displaying 261 - 280 of 344

Sort: Relevancy | Date

News Daily News

CMS Taking Another Look at Volume Requirements for TAVR Programs

Todd Neale

June 28, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

Caitlin E. Cox

August 18, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

Advertisement

CMS Taking Another Look at Volume Requirements for TAVR Programs

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Ticagrelor: Better Platelet Blockade Post-TAVR?

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

More Support for TMVR After Failed Mitral Bioprostheses

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content